Persistent Asset Partners »

Passage Bio shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Passage Bio (PASG) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Passage Bio

Tip: Access up to 7 years of quarterly data

All positions including Passage Bio held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Passage Bio by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $39k 5.0k 7.85

More positions owned by Persistent Asset Partners

Viking Therapeutics Call Option (VKTX)
Kodiak Sciences Call Option (KOD)
Corning Incorporated Call Option (GLW)
Eyepoint Com New Call Option (EYPT)
Corbus Pharmaceuticals Hldgs Com New Call Option (CRBP)
Capricor Therapeutics Com New Call Option (CAPR)
United Therapeutics Corporation Call Option (UTHR)
Lumentum Hldgs (LITE)
Sandisk Corp Put Option (SNDK)
Voyager Therapeutics Call Option (VYGR)
Axt (AXTI)
Vaxcyte Call Option (PCVX)
Intel Corporation (INTC)
Tower Semiconductor Shs New (TSEM)
Edgewise Therapeutics Call Option (EWTX)

View all positions for Persistent Asset Partners

Top funds holding Passage Bio

Lynx1 Capital Management
Vestal Point Capital
Vanguard Group
Eversept Partners
Vanguard Capital Management
Renaissance Technologies
Yiheng Capital
Erste Asset Management GmbH
Ikarian Capital
Geode Capital Management
BlackRock
UBS Group
Acadian Asset Management
Boothbay Fund Management
Vanguard Fiduciary Trust

View all funds holding Passage Bio